January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
OCMS Bio, LLC
OCMS technology screens millions of recombinant antibodies in mammalian cells for expression and antigen binding, discovering next generation antibody therapeutics targeting proven therapeutic pathways. OB2401 performed 5x better than market leader.